more patients on the new anticoagulant dabigatran (Pradaxa) instead of warfarin for nonvalvular atrial fibrillation

You'll see more patients on the new anticoagulant dabigatran (Pradaxa) instead of warfarin for nonvalvular atrial fibrillation....

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote